Abreu P - Search Results

1

An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America.

Nucci M, Colombo AL, Petti M, Magana M, Abreu P, Schlamm HT, Sanchez SP. Nucci M, et al. Among authors: abreu p. Mycoses. 2014 Jan;57(1):12-8. doi: 10.1111/myc.12094. Epub 2013 May 26. Mycoses. 2014. PMID: 23710653 Clinical Trial.

2

Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase.

Rabelo VW, Viegas DJ, Tucci EMN, Romeiro NC, Abreu PA. Rabelo VW, et al. J Steroid Biochem Mol Biol. 2019 Jan;185:189-199. doi: 10.1016/j.jsbmb.2018.09.001. Epub 2018 Sep 5. J Steroid Biochem Mol Biol. 2019. PMID: 30193921 Free article.

3

A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico).

Rivera-Castaño L, Leal-Cantu R, Abreu P, Guerrero M, Davila G. Rivera-Castaño L, et al. Among authors: abreu p. Epilepsy Res. 2012 Jun;100(1-2):74-9. doi: 10.1016/j.eplepsyres.2012.01.009. Epub 2012 Feb 2. Epilepsy Res. 2012. PMID: 22304935 Clinical Trial.

4

Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel.

Sathler PC, Santana M, Lourenço AL, Rodrigues CR, Abreu P, Cabral LM, Castro HC. Sathler PC, et al. Among authors: abreu p. J Enzyme Inhib Med Chem. 2014 Aug;29(4):527-31. doi: 10.3109/14756366.2013.817403. Epub 2013 Aug 5. J Enzyme Inhib Med Chem. 2014. PMID: 23914925

5

Targeting CYP51 for drug design by the contributions of molecular modeling.

Rabelo VW, Santos TF, Terra L, Santana MV, Castro HC, Rodrigues CR, Abreu PA. Rabelo VW, et al. Fundam Clin Pharmacol. 2017 Feb;31(1):37-53. doi: 10.1111/fcp.12230. Epub 2016 Aug 24. Fundam Clin Pharmacol. 2017. PMID: 27487199 Review.

6

Antiviral activity of 1,4-disubstituted-1,2,3-triazoles against HSV-1 in vitro.

Viegas DJ, da Silva VD, Buarque CD, Bloom DC, Abreu PA. Viegas DJ, et al. Antivir Ther. 2020;25(8):399-410. doi: 10.3851/IMP3387. Antivir Ther. 2020. PMID: 33705354

7

Design strategies of oxidosqualene cyclase inhibitors: Targeting the sterol biosynthetic pathway.

Rabelo VW, Romeiro NC, Abreu PA. Rabelo VW, et al. J Steroid Biochem Mol Biol. 2017 Jul;171:305-317. doi: 10.1016/j.jsbmb.2017.05.002. Epub 2017 May 4. J Steroid Biochem Mol Biol. 2017. PMID: 28479228 Review.

8

Computational strategy for visualizing structures and teaching biochemistry.

Abreu PA, Carvalho KL, Rabelo VW, Castro HC. Abreu PA, et al. Biochem Mol Biol Educ. 2019 Jan;47(1):76-84. doi: 10.1002/bmb.21199. Epub 2018 Dec 22. Biochem Mol Biol Educ. 2019. PMID: 30578716 Free article.

9

Targeting Chikungunya virus by computational approaches: from viral biology to the development of therapeutic strategies.

Rabelo VW, Paixão ICNP, Abreu PA. Rabelo VW, et al. Expert Opin Ther Targets. 2020 Jan;24(1):63-78. doi: 10.1080/14728222.2020.1712362. Epub 2020 Jan 9. Expert Opin Ther Targets. 2020. PMID: 31914351 Review.

10

Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma.

Zorzanelli BC, Ouverney G, Pauli FP, da Fonseca ACC, de Almeida ECP, de Carvalho DG, Possik PA, Rabelo VW, Abreu PA, Pontes B, Ferreira VF, Forezi LDSM, da Silva FC, Robbs BK. Zorzanelli BC, et al. Among authors: abreu pa. Molecules. 2022 Aug 12;27(16):5148. doi: 10.3390/molecules27165148. Molecules. 2022. PMID: 36014389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page